138 related articles for article (PubMed ID: 29266563)
1. Rat brain CYP2D activity alters in vivo central oxycodone metabolism, levels and resulting analgesia.
McMillan DM; Miksys S; Tyndale RF
Addict Biol; 2019 Mar; 24(2):228-238. PubMed ID: 29266563
[TBL] [Abstract][Full Text] [Related]
2. Sex, estrous cycle, and hormone regulation of CYP2D in the brain alters oxycodone metabolism and analgesia.
Arguelles N; Richards J; El-Sherbeni AA; Miksys S; Tyndale RF
Biochem Pharmacol; 2022 Apr; 198():114949. PubMed ID: 35143755
[TBL] [Abstract][Full Text] [Related]
3. Sex and Estrous Cycle Differences in Analgesia and Brain Oxycodone Levels.
Arguelles N; Miksys S; Tyndale RF
Mol Neurobiol; 2021 Dec; 58(12):6540-6551. PubMed ID: 34581987
[TBL] [Abstract][Full Text] [Related]
4. Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic response.
McMillan DM; Tyndale RF
Biochem Pharmacol; 2017 Dec; 145():158-168. PubMed ID: 28837793
[TBL] [Abstract][Full Text] [Related]
5. Centrally administered CYP2D inhibitors increase oral tramadol analgesia in rats.
McMillan DM; El-Sherbeni AA; Richards J; Tyndale RF
Brain Res Bull; 2020 Nov; 164():400-406. PubMed ID: 32926950
[TBL] [Abstract][Full Text] [Related]
6. Nicotine Increases Codeine Analgesia Through the Induction of Brain CYP2D and Central Activation of Codeine to Morphine.
McMillan DM; Tyndale RF
Neuropsychopharmacology; 2015 Jun; 40(7):1804-12. PubMed ID: 25630571
[TBL] [Abstract][Full Text] [Related]
7. First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo.
Zhou K; Khokhar JY; Zhao B; Tyndale RF
Biochem Pharmacol; 2013 Jun; 85(12):1848-55. PubMed ID: 23623752
[TBL] [Abstract][Full Text] [Related]
8. Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.
Lemberg KK; Kontinen VK; Siiskonen AO; Viljakka KM; Yli-Kauhaluoma JT; Korpi ER; Kalso EA
Anesthesiology; 2006 Oct; 105(4):801-12. PubMed ID: 17006080
[TBL] [Abstract][Full Text] [Related]
9. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
[TBL] [Abstract][Full Text] [Related]
10. CYP2D in the brain impacts oral hydrocodone analgesia in vivo.
Richards J; Miksys S; Novalen M; Tyndale RF
Neuropharmacology; 2022 Dec; 221():109291. PubMed ID: 36241086
[TBL] [Abstract][Full Text] [Related]
11. Rat brain CYP2D enzymatic metabolism alters acute and chronic haloperidol side-effects by different mechanisms.
Miksys S; Wadji FB; Tolledo EC; Remington G; Nobrega JN; Tyndale RF
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():140-148. PubMed ID: 28454738
[TBL] [Abstract][Full Text] [Related]
12. In vitro metabolism of specific CYP2D and CYP3A opioid substrates using rat liver S9 fractions and mass spectrometry reveal a severe metabolic impairment with increasing age.
Salmin SF; Giroux MC; Vachon P; Beaudry F
Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27390106
[TBL] [Abstract][Full Text] [Related]
13. Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients.
Lemberg KK; Heiskanen TE; Neuvonen M; Kontinen VK; Neuvonen PJ; Dahl ML; Kalso EA
Scand J Pain; 2010 Jan; 1(1):24-33. PubMed ID: 29913934
[TBL] [Abstract][Full Text] [Related]
14. Contribution of oxycodone and its metabolites to the overall analgesic effect after oxycodone administration.
Klimas R; Witticke D; El Fallah S; Mikus G
Expert Opin Drug Metab Toxicol; 2013 May; 9(5):517-28. PubMed ID: 23488585
[TBL] [Abstract][Full Text] [Related]
15. Oxymorphone active uptake at the blood-brain barrier and population modeling of its pharmacokinetic-pharmacodynamic relationship.
Sadiq MW; Boström E; Keizer R; Björkman S; Hammarlund-Udenaes M
J Pharm Sci; 2013 Sep; 102(9):3320-31. PubMed ID: 23463542
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic effects of oral oxymorphone: abuse liability, analgesic profile and direct physiologic effects in humans.
Babalonis S; Lofwall MR; Nuzzo PA; Walsh SL
Addict Biol; 2016 Jan; 21(1):146-58. PubMed ID: 25130052
[TBL] [Abstract][Full Text] [Related]
17. Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.
Yue J; Miksys S; Hoffmann E; Tyndale RF
J Psychiatry Neurosci; 2008 Jan; 33(1):54-63. PubMed ID: 18197273
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.
Chan S; Edwards SR; Wyse BD; Smith MT
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):295-302. PubMed ID: 17973932
[TBL] [Abstract][Full Text] [Related]
19. Zhx2 Is a Candidate Gene Underlying Oxymorphone Metabolite Brain Concentration Associated with State-Dependent Oxycodone Reward.
Beierle JA; Yao EJ; Goldstein SI; Lynch WB; Scotellaro JL; Shah AA; Sena KD; Wong AL; Linnertz CL; Averin O; Moody DE; Reilly CA; Peltz G; Emili A; Ferris MT; Bryant CD
J Pharmacol Exp Ther; 2022 Aug; 382(2):167-180. PubMed ID: 35688478
[TBL] [Abstract][Full Text] [Related]
20. CYP2D6 pharmacogenetic and oxycodone pharmacokinetic association study in pediatric surgical patients.
Balyan R; Mecoli M; Venkatasubramanian R; Chidambaran V; Kamos N; Clay S; Moore DL; Mavi J; Glover CD; Szmuk P; Vinks A; Sadhasivam S
Pharmacogenomics; 2017 Mar; 18(4):337-348. PubMed ID: 28244808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
